Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
MAIA

Updated 10/6/2026, 3:28 PM ET.

MAIA

MAIA Biotechnology, Inc.

Buy$100,010

Vitoc Vlad

Chief Executive Officer, Director, 10% owner

73,000 shat $1.37Filed Sep 15, 6:33 AM ETFiling
MAIA

MAIA Biotechnology, Inc.

Buy$49,516

Guerrero Ramiro

Director

37,595 shat $1.32Filed Sep 14, 9:03 AM ETFiling
MAIA

MAIA Biotechnology, Inc.

Buy$184,103

Guerrero Ramiro

Director

133,790 shat $1.38Filed Sep 1, 4:16 PM ETFiling
MAIA

MAIA Biotechnology, Inc.

Buy$2,386

Guerrero Ramiro

Director

1,794 shat $1.33Filed Aug 26, 7:56 AM ETFiling
MAIA

MAIA Biotechnology, Inc.

Buy$16,302

Guerrero Ramiro

Director

11,899 shat $1.37Filed Aug 24, 4:09 PM ETFiling

Read from public SEC filings. Not financial advice.